Endologix to Report Fourth Quarter and Full Year 2011 Financial Results on February 22, 2012
February 10 2012 - 9:00AM
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally
invasive treatments for aortic disorders, announced today details
relating to the release of its fourth quarter and full year 2011
financial results, which will take place on Wednesday, February 22,
2012 after the close of the market.
Endologix will hold a conference call on Wednesday, February 22,
2012 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The
dial-in numbers are (877) 407-0789 for domestic callers and (201)
689-8562 for international callers. A live webcast of the
conference call will be available online from the investor
relations page of the Company's corporate website at
www.endologix.com.
After the live webcast, the call will remain available on
Endologix's website, www.endologix.com, through March 22, 2012. In
addition, a telephonic replay of the call will be available until
February 29, 2012. The replay dial-in numbers are (877) 870-5176
for domestic callers and (858) 384-5517 for international callers.
Please use the replay pin number 388474.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it a leading cause of death in the U.S. Additional
information can be found on Endologix's website at
www.endologix.com.
CONTACT: COMPANY CONTACT:
Endologix, Inc.
John McDermott, CEO
(949) 595-7200
www.endologix.com
INVESTOR CONTACTS:
The Ruth Group
Nick Laudico (646) 536-7030
Zack Kubow (646) 536-7020
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Oct 2023 to Oct 2024